Waverley Pharma Inc. (FRA:5GZ)
Germany · Delayed Price · Currency is EUR 0.0080
0.00 (0.00%)
Last updated: Jan 9, 2026, 8:59 AM CET
Waverley Pharma Market Cap
Waverley Pharma has a market cap or net worth of €668.44 thousand as of January 9, 2026. Its market cap has decreased by -82.98% in one year.
Market Cap
668.44K
Enterprise Value
2.62M
Revenue
921.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.01
Market Cap Chart
Since October 27, 2017, Waverley Pharma's market cap has decreased from 18.12M to 668.44K, a decrease of -96.31%. That is a compound annual growth rate of -33.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 668.44K | 84.40% |
| Dec 31, 2024 | 362.50K | -60.78% |
| Dec 22, 2023 | 924.24K | -17.63% |
| Dec 28, 2022 | 1.12M | -62.40% |
| Dec 30, 2021 | 2.98M | -31.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |